Baird Reiterates an 'Outperform' on Endocyte (ECYT); Doxil Shortage May Present a Real Risk to PROCEED Timelines
Go back to Baird Reiterates an 'Outperform' on Endocyte (ECYT); Doxil Shortage May Present a Real Risk to PROCEED Timelines| ENDOCYTE (NASDAQ: ECYT) | Delayed: 23.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.99 | 52 Week High | $4.89 | |||
| Open | $25.06 | 52 Week Low | $2.62 | |||
| Day High | $23.99 | P/E | N/A | |||
| Day Low | $23.99 | EPS | $-0.44 | |||
| Volume | 0 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 262.37 +2.02 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $260.35 | 52 Week High | $126.07 | |||
| Open | $258.87 | 52 Week Low | $94.28 | |||
| Day High | $264.28 | P/E | 54.55 | |||
| Day Low | $258.01 | EPS | $4.81 | |||
| Volume | 5,506,557 | |||||
